Galectin Therapeutics Competitors and Similar CompaniesClear all
Galectin Therapeutics's competitors and similar companies include Vivace Therapeutics, Clovis Oncology, Khloris Biosciences and Kyowa Kirin.
 Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. |  Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. |  Khloris Biosciences Khloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | ||
Founding Date | Founding Date 2001 | Founding Date 2014 | Founding Date 2009 | Founding Date 2017 | Founding Date 2008 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Norcross, US HQ | Locations San Mateo, US HQ | Locations Mountain View, US HQ | ||
Employees | Employees 717% increase | Employees 1122% increase | Employees 4843% increase | Employees 1214% decrease | Employees 5,669 |
Valuation ($) | Valuation ($) 155.1 m | Valuation ($) N/A | Valuation ($) 10.6 m | Valuation ($) N/A | Valuation ($) 8.8 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) ¥496.8b (FY, 2025) |
Net income | Net income ($30.8m) (FY, 2025) | Net income N/A | Net income ($264.5m) (FY, 2021) | Net income N/A | Net income ¥67b (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 30m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 5m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 70m | Total funding raised $ 357m | Total funding raised $ 5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Vivace Therapeutics
HQ
San Mateo, US
Employees
11↑ 22% increase
Vivace Therapeutics is a pharmaceutical company.
View companyClovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View companyKhloris Biosciences
HQ
Mountain View, US
Employees
12↓ 14% decrease
Khloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases.
View companyKyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company